BCRX

BioCryst Pharmaceuticals (BCRX)

About BioCryst Pharmaceuticals (BCRX)

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Details

Daily high
$7.60
Daily low
$7.25
Price at open
$7.25
52 Week High
$8.88
52 Week Low
$4.03
Market cap
1.6B
Dividend yield
0.00%
Volume
5.1M
Avg. volume
2.0M
P/E ratio
-12.46

BioCryst Pharmaceuticals News

Details

Daily high
$7.60
Daily low
$7.25
Price at open
$7.25
52 Week High
$8.88
52 Week Low
$4.03
Market cap
1.6B
Dividend yield
0.00%
Volume
5.1M
Avg. volume
2.0M
P/E ratio
-12.46